BDSX Stock Analysis: Buy, Sell, or Hold?
BDSX - Biodesix, Inc. Common Stock
$21.99
-2.51 (-10.24%)
▼
5d:
+9.73%
30d:
+42.42%
90d:
+48.98%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BDSX is 7.2% above its trading range ($20.51). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BDSX is 7.2% above its trading range ($20.51). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $21.99, which is considered extended relative to its 30-day fair value range of $14.33 to $20.51.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $15.26, while resistance sits at $24.92. Short-term momentum is weak, with the stock down 10.2% recently.
Market Sentiment: BDSX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.83 (+40.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $15.26, while resistance sits at $24.92. Short-term momentum is weak, with the stock down 10.2% recently.
Market Sentiment: BDSX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.83 (+40.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.33 -
$20.51
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range (+7.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.2%)
- BULLISH: Trading 40.2% below Wall St target ($30.83)
Trading Range Analysis
30-Day Trading Range
$14.33 -
$20.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.26
Resistance Level
$24.92
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.45
Wall Street Target
$30.83
(+40.2%)
Revenue Growth (YoY)
42.3%
Profit Margin
-33.3%
Share & Embed Analysis
Last updated: July 02, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Gary Anthony Pestano
SELL
556 shares
2026-02-23
Kieran O'kane
SELL
535 shares
2026-02-23
Robin Harper Cowie
SELL
535 shares
2026-02-23
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
